Organ Transplantation in Australia
Research Highlights
Epigenetic Remodeling in Exhausted T Cells
Thomas Earl Starzl, MD, PhD, Transplant Pioneer, Polymath, Mentor, March 11th, 1926–March 4th, 2017
Timing Is Everything
Laparoscopic Donor Hepatectomy
One More Step Toward a Clinically Applicable Tolerance Induction Protocol in Solid Organ Transplantation?
Immune Reconstitution After HCV Clearance With Direct Antiviral Agents
The Path to Cancer and Back
Disease Reversibility in Patients With Post-Hepatitis C Cirrhosis
HCV Antiviral Therapy in Liver Transplant Candidates and Recipients With Renal Insufficiency
Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C
The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients
Use of HCV+ Donors Does Not Affect HCV Clearance With Directly Acting Antiviral Therapy But Shortens the Wait Time to Kidney Transplantation
Successful Posttransplant Treatment of Hepatitis C With Ledipasvir-Sofosbuvir in HIV+ Kidney Transplant Recipients
Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients
The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis
Sofosbuvir/Ledipasvir Without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence After Liver Transplantation
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C–Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma
Successful Continuation of HCV Treatment After Liver Transplantation
Activated Renal Dendritic Cells Cross Present Intrarenal Antigens After Ischemia-Reperfusion Injury
Effects of Composition of Alginate-Polyethylene Glycol Microcapsules and Transplant Site on Encapsulated Islet Graft Outcomes in Mice
Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal Transplantation
Transplant Site Influences the Immune Response After Islet Transplantation
Association of Local Intrapulmonary Production of Antibodies Specific to Donor Major Histocompatibility Complex Class I With the Progression of Chronic Rejection of Lung Allografts
Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance
Interpreting Outcomes in DCDD Liver Transplantation
Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis
Normothermic Perfusion in the Assessment and Preservation of Declined Livers Before Transplantation
Characterizing the Risk of False-Positive Hepatocellular Carcinoma in Recipients Transplanted With T2 MELD Exceptions
Initial Outcomes of Pure Laparoscopic Living Donor Right Hepatectomy in an Experienced Adult Living Donor Liver Transplant Center
Hypereosinophilic Syndrome After Liver Transplantation
Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation
HLA Amino Acid Polymorphisms and Kidney Allograft Survival
Diffuse Extent of Peritubular Capillaritis in Late Antibody-Mediated Rejection
Donor-specific Anti-HLA Antibodies Present in Pooled Human Serum Do Not Prevent Development of Human Mreg_UKR From Monocytes in Culture
Severe Transplantation-Mediated Alloimmune Thrombocytopenia in 2 Recipients of Organs From the Same Donor
Hepatitis C–Positive Kidney Transplant Recipients—When Is The Best Time to Treat With Direct-Acting Antiviral Agents?
Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection